The long market slowdown which began with acute phase of the crisis ended only in Q4 2016. Last year was marked by the loss of leading positions and a drop in retail sales of original medicinal products; at the same time, we noted the active development of niche branded generics, said Nikolai Demidov, General Director of IMS Health Russia and CIS.
He pointed out to the trends in physical sales of nifuroxazide, an original antibiotic, and its generic as an example illustrating the displacement of original medicines by generic drugs. The percentage of original nifuroxazide (in packages) in the sales fell down from 8.8% in 2014 to 2.8% in 2016, while the principal demand (91.2% in 2014 and 97.2% in 2016) was for generics. A similar situation is with the sales of loperamide, an antidiarrhoea drug. In two years, the demand for original medicinal product dropped from 9.3% to 6.9%.
Amid growing demand for inexpensive medicines, the manufacturers of generics strengthen their positions in the Russian pharmaceutical market.